The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage

被引:13
|
作者
White, C. Roger [1 ]
Datta, Geeta [1 ]
Wilson, Landon [3 ]
Palgunachari, Mayakonda N. [1 ]
Anantharamaiah, G. M. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
ApoA-I; ApoA-I mimetic peptide; Hypochlorous acid; Oxidation; Cholesterol efflux; HIGH-DENSITY-LIPOPROTEIN; CORONARY ATHEROSCLEROSIS; HDL; NANOPARTICLES; CHOLESTEROL; DISEASE; MILANO;
D O I
10.1016/j.chemphyslip.2019.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [21] Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis
    Moreira, Roberto S.
    Irigoyen, Maria
    Sanches, Talita R.
    Volpini, Rildo A.
    Camara, Niels O. S.
    Malheiros, Denise M.
    Shimizu, Maria H. M.
    Seguro, Antonio C.
    Andrade, Lucia
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 307 (05) : R514 - R524
  • [22] Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
    Peng, Meiyu
    Zhang, Qi
    Cheng, Yingnan
    Fu, Shuyu
    Yang, Huipeng
    Guo, Xiangdong
    Zhang, Jieyou
    Wang, Lina
    Zhang, Lijuan
    Xue, Zhenyi
    Li, Yan
    Da, Yurong
    Yao, Zhi
    Qiao, Liang
    Zhang, Rongxin
    ONCOTARGET, 2017, 8 (59) : 99693 - 99706
  • [23] Apolipoprotein A-I (apoA-I) and markers of inflammation in coronary heart disease
    Schlitt, A
    Rupprecht, HJ
    Blankenberg, S
    Bickel, C
    Hafner, G
    Rippin, G
    Meyer, J
    EUROPEAN HEART JOURNAL, 2000, 21 : 627 - 627
  • [24] ABCA1 (ATP-Binding Cassette Transporter A1) Mediates ApoA-I (Apolipoprotein A-I) and ApoA-I Mimetic Peptide Mobilization of Extracellular Cholesterol Microdomains Deposited by Macrophages
    Jin, Xueting
    Sviridov, Denis
    Liu, Ying
    Vaisman, Boris
    Addadi, Lia
    Remaley, Alan T.
    Kruth, Howard S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (12) : 2283 - 2291
  • [25] Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells
    Ohnsorg, Pascale M.
    Rohrer, Lucia
    Perisa, Damir
    Kateifides, Andreas
    Chroni, Angeliki
    Kardassis, Dimitris
    Zannis, Vassilis I.
    von Eckardstein, Arnold
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) : 7744 - 7754
  • [26] Cumulative Brain Injury from Motor Vehicle-Induced Whole-Body Vibration and Prevention by Human Apolipoprotein A-I Molecule Mimetic (4F) Peptide (an Apo A-I Mimetic)
    Yan, Ji-Geng
    Zhang, Lin-ling
    Agresti, Michael
    Yan, Yuhui
    LoGiudice, John
    Sanger, James R.
    Matloub, Hani S.
    Pritchard, Kirkwood A., Jr.
    Jaradeh, Safwan S.
    Havlik, Robert
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (12): : 2759 - 2773
  • [27] TISSUE-SPECIFIC EXPRESSION OF APOLIPOPROTEIN A-I (APOA-I) IS REGULATED BY THE 5'-FLANKING REGION OF THE HUMAN APOA-I GENE
    HIGUCHI, K
    LAW, SW
    HOEG, JM
    SCHUMACHER, UK
    MEGLIN, N
    BREWER, HB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (34) : 18530 - 18536
  • [28] TISSUE-SPECIFIC EXPRESSION OF APOLIPOPROTEIN A-I (APOA-I) IS REGULATED BY THE 5'-FLANKING REGION OF THE HUMAN APOA-I GENE
    HIGUCHI, K
    LAW, SW
    HOEG, JM
    BREWER, HB
    CIRCULATION, 1987, 76 (04) : 221 - 221
  • [29] Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p
    Sharma, Salil
    Umar, Soban
    Potus, Francois
    Iorga, Andrea
    Wong, Gabriel
    Meriwether, David
    Breuils-Bonnet, Sandra
    Mai, Denise
    Navab, Kaveh
    Ross, David
    Navab, Mohamad
    Provencher, Steeve
    Fogelman, Alan M.
    Bonnet, Sebastien
    Reddy, Srinivasa T.
    Eghbali, Mansoureh
    CIRCULATION, 2014, 130 (09) : 776 - +
  • [30] The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells
    Theodoros, Kelesidis
    Sharma, Madhav
    Anton, Petcherski
    Hugo, Cristelle
    Ellen, O'Connor
    Hultgren, Nan W.
    Ritou, Eleni
    Williams, David S.
    Orian, Shirihai S.
    Srinivasa, Reddy T.
    VIRULENCE, 2021, 12 (01) : 2214 - 2227